These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3879843)

  • 1. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to envelope proteins of human and animal retroviruses.
    Cianciolo GJ; Bogerd HP; Kipnis RJ; Copeland TD; Oroszlan S; Snyderman R
    Trans Assoc Am Physicians; 1985; 98():30-41. PubMed ID: 3879843
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of murine cytotoxic T lymphocyte activity by a synthetic retroviral peptide and abrogation of this activity by IL.
    Ogasawara M; Haraguchi S; Cianciolo GJ; Mitani M; Good RA; Day NK
    J Immunol; 1990 Jul; 145(2):456-62. PubMed ID: 2195116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive actions of retroviruses.
    Good RA; Ogasawara M; Liu WT; Lorenz E; Day NK
    Lymphology; 1990 Jun; 23(2):56-9. PubMed ID: 2170777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus.
    Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P
    Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses.
    Harrell RA; Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R
    J Immunol; 1986 May; 136(10):3517-20. PubMed ID: 3701057
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.
    Selby M; Erickson A; Dong C; Cooper S; Parham P; Houghton M; Walker CM
    J Immunol; 1999 Jan; 162(2):669-76. PubMed ID: 9916684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.
    Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R
    Science; 1985 Oct; 230(4724):453-5. PubMed ID: 2996136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones.
    Bonneau RH; Salvucci LA; Johnson DC; Tevethia SS
    Virology; 1993 Jul; 195(1):62-70. PubMed ID: 7686314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE; Yasukawa LL; Bergen R; Benike C; Engleman EG; Arvin AM
    J Immunol; 1999 Jan; 162(1):560-7. PubMed ID: 9886433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses.
    Kageyama S; Tsomides TJ; Sykulev Y; Eisen HN
    J Immunol; 1995 Jan; 154(2):567-76. PubMed ID: 7814868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocyte responses to the envelope proteins of endogenous ecotropic and mink cytopathic focus-forming murine leukemia viruses in H-2b mice.
    Coppola MA; Green WR
    Virology; 1994 Jul; 202(1):500-5. PubMed ID: 7516600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.
    Bruña-Romero O; Lasarte JJ; Wilkinson G; Grace K; Clarke B; Borrás-Cuesta F; Prieto J
    Hepatology; 1997 Feb; 25(2):470-7. PubMed ID: 9021966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.
    Haynes BF; Yasutomi Y; Torres JV; Gardner MB; Langlios AJ; Bolognesi DP; Matthews TJ; Scearce RM; Jones DM; Moody MA
    Trans Assoc Am Physicians; 1993; 106():33-41. PubMed ID: 8036743
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope.
    Bonneau RH; Fu TM; Tevethia SS
    Virology; 1993 Dec; 197(2):782-7. PubMed ID: 7504370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis.
    Purtha WE; Myers N; Mitaksov V; Sitati E; Connolly J; Fremont DH; Hansen TH; Diamond MS
    Eur J Immunol; 2007 Jul; 37(7):1845-54. PubMed ID: 17559174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation.
    Cianciolo GJ; Bogerd H; Snyderman R
    Immunol Lett; 1988 Sep; 19(1):7-13. PubMed ID: 2973436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.